REPLIMUNE GROUP INC. - COMMON STOCK
8,5000
28-мая-25 11:47:48
15 мин. задержка
Акции
+0,0800
+0,95%
Сегодняшний диапазон
8,2500 - 8,7700
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
15 сен 2024 06:45:00 Источник Nasdaq GlobeNewswire
-
09 сен 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Stockholders Vote to Elect Madhavan Balachandran to Board of Directors
05 сен 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
22 авг 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
13 авг 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Replimune Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update
08 авг 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Replimune to Present at Two Upcoming Investor Conferences
30 июл 2024 13:01:00 Источник Nasdaq GlobeNewswire
-
Replimune Announces $100 Million Private Placement Financing
13 июн 2024 05:30:00 Источник Nasdaq GlobeNewswire
-
Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
07 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
06 июн 2024 04:00:00 Источник Nasdaq GlobeNewswire
-
03 июн 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
23 май 2024 14:00:00 Источник Nasdaq GlobeNewswire
-
16 май 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
07 апр 2024 14:00:00 Источник Nasdaq GlobeNewswire
-
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 апр 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
26 мар 2024 04:30:00 Источник Nasdaq GlobeNewswire
-
Replimune to Present at the American Association for Cancer Research Annual Meeting 2024
06 мар 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Replimune to Present at Three Upcoming Investor Conferences
05 мар 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Replimune Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
08 фев 2024 05:00:01 Источник Nasdaq GlobeNewswire
-
Replimune to Present at the 42nd Annual J.P. Morgan Healthcare Conference
28 дек 2023 05:00:00 Источник Nasdaq GlobeNewswire